SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching
SNDL Inc. shares rose sharply Friday after reports that the Trump administration may seek to reclassify marijuana as a Schedule III drug. The Washington Post and Reuters said no final decision has been made, but the move could ease research restrictions and improve industry economics. SNDL was among the top cannabis gainers in premarket trading.